Current and resolved drug shortages and discontinuations reported to the FDA, Food and Drug Administration (2024) Regulatory framework for compounded preparations, National Academies Press (2020) Clinical and legal considerations in pharmaceutical compounding, The Journal of Clinical and Aesthetic Dermatology (2023) FDA alerts health care providers, compounders, and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024) Medications containing semaglutide marketed for Type 2 diabetes or weight loss, Food and Drug Administration (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

A person sweating through opioid withdrawal, doubled over with cramps, looks far more alarming than someone in the first quiet hours of alcohol withdrawal who just feels shaky and anxious
These medications work by mimicking natural hormones that regulate hunger and satiety signals, effectively rewiring the bodys relationship with food
Never pack GLP-1 injections in carry-on bags exposed to aircraft cabin heat or in checked luggage subject to cargo freezing